These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1974963)

  • 1. Antibodies to cerebellar soluble lectin in multiple sclerosis.
    Hughes RA
    Lancet; 1990 Aug; 336(8712):438-9. PubMed ID: 1974963
    [No Abstract]   [Full Text] [Related]  

  • 2. [Presence of antibodies to lectin CSL in the blood of patients with multiple sclerosis patients].
    Zanetta JP; Warter JM; Lehmann S; Tranchant C; Kuchler S; Vincendon G
    C R Acad Sci III; 1990; 311(9):327-31. PubMed ID: 2128203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is Cerebellar Soluble Lectin a major immunological target in multiple sclerosis?].
    Zanetta JP; Warter JM; Lehmann S; Kuchler S; Vincendon G
    Pathol Biol (Paris); 1991 Jan; 39(1):7-11. PubMed ID: 2011413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of anti-CSL antibodies in the cerebrospinal fluid of patients: a sensitive and specific test in the diagnosis of multiple sclerosis.
    Zanetta JP; Tranchant C; Kuchler-Bopp S; Lehmann S; Warter JM
    J Neuroimmunol; 1994 Jul; 52(2):175-82. PubMed ID: 8034757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to cerebellar soluble lectin CSL in multiple sclerosis.
    Zanetta JP; Warter JM; Kuchler S; Marschal P; Rumbach L; Lehmann S; Tranchant C; Reeber A; Vincendon G
    Lancet; 1990 Jun; 335(8704):1482-4. PubMed ID: 1972431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid anti-cerebellar soluble lectin antibodies in human immunodeficiency virus type 1 infection.
    Hagberg L; Norkrans G; Zanetta JP; Lehmann S; Bergström T
    J Neuroimmunol; 1992 Feb; 36(2-3):245-9. PubMed ID: 1732284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement-fixing antibrain antibodies in multiple sclerosis. A preliminary report.
    Laurell AB; Link H
    Acta Neurol Scand; 1972; 48(4):461-6. PubMed ID: 5072655
    [No Abstract]   [Full Text] [Related]  

  • 8. Intrathecal Rubella and RNA antibody synthesis in multiple sclerosis and progressive rubella panencephalitis.
    Schuller E; Delasnerie N; Allinquant B; Lebon P
    Biomedicine; 1977 Jun; 27(4):139-41. PubMed ID: 890020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration in tissue culture of myelinotoxicity in cerebrospinal fluid and brain extracts from multiple sclerosis patients.
    Kim SU; Murray MR; Tourtellotte WW; Parker JA
    J Neuropathol Exp Neurol; 1970 Jul; 29(3):420-31. PubMed ID: 5310945
    [No Abstract]   [Full Text] [Related]  

  • 10. CSF analysis in multiple sclerosis.
    Sindic CJ
    Acta Neurol Belg; 1994; 94(2):103-11. PubMed ID: 8036877
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoblot detection of oligoclonal anti-myelin basic protein IgG antibodies in cerebrospinal fluid in multiple sclerosis.
    Cruz M; Olsson T; Ernerudh J; Höjeberg B; Link H
    Neurology; 1987 Sep; 37(9):1515-9. PubMed ID: 2442667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: the relationship between measles virus-specific antibodies and oligoclonal IgG in the cerebrospinal fluid in patients with multiple sclerosis.
    Norrby E; Vandik B
    Neurology; 1975 May; 25(5):493. PubMed ID: 1169717
    [No Abstract]   [Full Text] [Related]  

  • 13. Virus specific antibodies in multiple sclerosis.
    Fraser KB; Haire M; Millar JH
    Br Med J; 1972 Aug; 3(5824):471. PubMed ID: 4341646
    [No Abstract]   [Full Text] [Related]  

  • 14. The relationship between measles virus-specific antibodies and oligoclonal IgG in the cerebrospinal fluid from patients with subacute sclerosing panencephalitis and multiple sclerosis.
    Norrby E; Link H
    Acta Neurol Scand Suppl; 1977; 63():161-71. PubMed ID: 265664
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple sclerosis and elevation of cerebrospinal fluid vaccinia virus antibody.
    Thompson JA; Bray PF; Glasgow LA
    Neurology; 1975 Jan; 25(1):94-6. PubMed ID: 1167412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin abnormalities in spinal fluid in multiple sclerosis.
    Link H; Möller E; Muller R; Norrby E; Olsson JE; Stendahl L; Tibbling G
    Acta Neurol Scand Suppl; 1977; 63():173-91. PubMed ID: 265665
    [No Abstract]   [Full Text] [Related]  

  • 17. Measles antibodies in multiple sclerosis patients.
    Caputo D; Ferrante P; Fasan M; Procaccia S
    Boll Ist Sieroter Milan; 1981; 60(1):57-60. PubMed ID: 7272013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin abnormalities in multiple sclerosis.
    Link H
    Ann Clin Res; 1973 Oct; 5(5):330-6. PubMed ID: 4209372
    [No Abstract]   [Full Text] [Related]  

  • 19. Purification of primary antibodies of the myelin basic protein antibody cascade from multiple sclerosis patients. Immunoreactivity studies with homologous and heterologous antigens.
    Warren KG; Catz I
    Clin Invest Med; 1992 Feb; 15(1):18-29. PubMed ID: 1373999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a 58-kDa antigen with increased immunoreactivity in the cerebella of multiple sclerosis patients.
    Peuchen S; Gruemer HD; DeVries GH
    J Neuroimmunol; 1992 Nov; 41(1):71-9. PubMed ID: 1460094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.